Executive Summary

Research teams, systematic reviewers, regulatory groups and enterprise R&D organizations routinely spend weeks to months extracting semi-structured data from publications, producing inconsistent evidence tables that hurt reproducibility and decision speed. This is an addressable problem for roughly 200,000 research groups and organizations—a $12.0B market if buyers are willing to pay about $60K annual contract value (ACV) for tooling that materially reduces manual extraction and creates auditable outputs. You could build a SaaS platform that ingests PDFs, tables and figures and applies a hybrid pipeline of deterministic, user-definable extraction rules plus LLM-assisted parsers to normalize findings into a single canonical table with provenance and versioned audit trails. Core product capabilities would include point-and-click rule authoring, human-in-the-loop validation workflows, export to common systematic-review formats, enterprise SSO and an API, aimed initially at mid-market and enterprise buyers at the expected $60K ACV. The timing is favorable: LLM-driven automation now makes semi-structured extraction practical, journals and funders are raising reproducibility requirements, and enterprise R&D budgets are shifting toward digitization—reflected in a market score of 90/100 and a revenue potential of 88/100. To stand out in a medium-competition landscape you must demonstrate measurable accuracy and time-savings, provide robust provenance and versioning, and ship domain-specific adapters (clinical trials, materials science, policy) rather than a one-size-fits-all model, because domain heterogeneity and regulatory acceptance are real obstacles. The main challenges are acquiring labeled data for specialist domains, building trust with reviewers and regulators, and managing longer sales cycles for $60K ACV deals, but a focused go-to-market into pharma, CROs and policy shops that prize auditability can justify initial investment and create a platform that later expands into academia and smaller labs.

Market Opportunity

Consistent evidence extraction: apply unified rules to turn papers into one table targets a $12.0B = 200,000 research groups/organizations x $60K ACV total addressable market with medium saturation and a year-over-year growth rate of 18% — enterprise research and analytics tooling adoption.

Key trends driving demand: LLM-driven automation -- models now extract semi-structured data from text and tables, reducing manual labor in literature reviews.; Reproducibility & open science -- funders and journals demand transparent evidence synthesis workflows, increasing demand for auditable extraction tools.; Enterprise R&D digitization -- pharma, CROs and policy shops are investing in tooling to speed reviews and regulatory submissions.; Shift to cloud and collaboration -- distributed review teams need shared, versioned evidence tables rather than scattered spreadsheets..

Key competitors include DistillerSR (Evidence Partners), Elicit (Ought), Covidence, Rayyan, Workarounds: Excel / Zotero / Google Sheets.

Sign in to access

Consistent evidence extraction: apply unified rules to turn papers into one table

Executive Summary

Market Validation

Market Opportunity

More in Data & Analytics

Automated reporting for data/ML pipelines that generates model-aware operational reports

Stop full-table scans on lakehouses with spatial + time indexing

SaaS founders can't explain churn — automated root‑cause analysis & recovery

SEC JS-pagination blocks comment scraping — build headless crawler + NLP index

Restore Excel & human-in-loop workflows for modern BI/AI pipelines

Measure real process bottlenecks first — then automate with robots